Diagnose und Therapie der Skleritis bei entzündlichen Systemerkrankungen

C. Tappeiner; A. Heiligenhaus

doi:10.1055/s-0031-1273325

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Klin Monbl Augenheilkd 2011; 228(5): 419-424
DOI: 10.1055/s-0031-1273325

Übersicht

Diagnose und Therapie der Skleritis bei entzündlichen Systemerkrankungen

Diagnosis and Treatment of Scleritis Associated to Inflammatory Systemic DiseasesC. Tappeiner¹ , A. Heiligenhaus²

¹Universitätsklinik für Augenheilkunde, Inselspital, Universität Bern
²Augenabteilung am St. Franziskus Hospital, Münster; Universität Essen

Further Information

Publication History

Eingegangen: 1.1.2011

Angenommen: 21.3.2011

Publication Date:
29 April 2011 (online)

Also available at

Abstract
Full Text
References

Permissions and Reprints

Zusammenfassung

Aufgrund potenziell visusbedrohender Komplikationen und der Assoziation zu Systemerkrankungen mit einer erhöhten Mortalität sind bei Skleritiden eine gezielte Diagnostik und eine frühzeitige und aggressive entzündungshemmende Systemtherapie notwendig. Neue therapeutische Optionen (wie z. B. Biologica) können in ansonsten therapieresistenten Fällen eine Remission erzielen.

Abstract

Because of potential vision-threatening complications and the association to inflammatory systemic diseases with an increased mortality, scleritis patients need an adequate diagnostic work-up and early and aggressive anti-inflammatory systemic treatment. New therapeutic options (such as biologicals) help to achieve remission in otherwise refractory cases.

Schlüsselwörter

Skleritis - Diagnose - Therapie

Key words

scleritis - diagnosis - treatment

Literatur

1 Okhravi N, Odufuwa B, McCluskey P et al. Scleritis. Surv Ophthalmol. 2005; 50 351-363

Google Scholar
2 Sainz de la Maza M, Jabbur N S, Foster C S. Severity of scleritis and episcleritis. Ophthalmology. 1994; 101 389-396

Google Scholar
3 Jabs D A, Rosenbaum J T, Foster C S et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000; 130 492-513

Google Scholar
4 Albini T A, Rao N A, Smith R E. The diagnosis and management of anterior scleritis. Int Ophthalmol Clin. 2005; 45 191-204

Google Scholar
5 Rachitskaya A, Mandelcorn E D, Albini T A. An update on the cause and treatment of scleritis. Curr Opin Ophthalmol. 2010; 21 463-467

Google Scholar
6 Sainz de la Maza M, Foster C S, Jabbur N S. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995; 102 687-692

Google Scholar
7 Raiji V R, Palestine A G, Parver D L. Scleritis and systemic disease association in a community-based referral practice. Am J Ophthalmol. 2009; 148 946-950

Google Scholar
8 Afshari N A, Afshari M A, Foster C S. Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep. 2001; 3 453-458

Google Scholar
9 Bullen C L, Liesegang T J, McDonald T J et al. Ocular complications of Wegener’s granulomatosis. Ophthalmology. 1983; 90 279-290

Google Scholar
10 Isaak B L, Liesegang T J, Michet Jr C J. Ocular and systemic findings in relapsing polychondritis. Ophthalmology. 1986; 93 681-689

Google Scholar
11 Tuft S J, Watson P G. Progression of scleral disease. Ophthalmology. 1991; 98 467-471

Google Scholar
12 Foster C S. Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology. 1980; 87 140-150

Google Scholar
13 Watson P G, Hayreh S S. Scleritis and episcleritis. Br J Ophthalmol. 1976; 60 163-191

Google Scholar
14 Rao N A, Marak G E, Hidayat A A. Necrotizing scleritis. A clinico-pathologic study of 41 cases. Ophthalmology. 1985; 92 1542-1549

Google Scholar
15 Hemady R, Sainz de la Maza M, Raizman M B et al. Six cases of scleritis associated with systemic infection. Am J Ophthalmol. 1992; 114 55-62

Google Scholar
16 Feiz V, Redline D E. Infectious scleritis after pars plana vitrectomy because of methicillin-resistant Staphylococcus aureus resistant to fourth-generation fluoroquinolones. Cornea. 2007; 26 238-240

Google Scholar
17 Howell A, Midturi J, Sierra-Hoffman M et al. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin. Med Mycol. 2005; 43 651-655

Google Scholar
18 Huang F C, Huang S P, Tseng S H. Management of infectious scleritis after pterygium excision. Cornea. 2000; 19 34-39

Google Scholar
19 Hwang Y S, Chen Y F, Lai C C et al. Infectious scleritis after use of immunomodulators. Arch Ophthalmol. 2002; 120 1093-1094

Google Scholar
20 Meyer J J, Espandar L, Marx D P et al. Pseudomonas scleritis resistant to fourth-generation fluoroquinolones in a patient without prior trauma or surgery. Ocul Immunol Inflamm. 2008; 16 127-129

Google Scholar
21 Moreno Honrado M, del Campo Z, Buil J A. A case of necrotizing scleritis resulting from Pseudomonas aeruginosa. Cornea. 2009; 28 1065-1066

Google Scholar
22 Rich R M, Smiddy W E, Davis J L. Infectious scleritis after retinal surgery. Am J Ophthalmol. 2008; 145 695-699

Google Scholar
23 Seth R K, Gaudio P A. Nocardia asteroides necrotizing scleritis associated with subtenon triamcinolone acetonide injection. Ocul Immunol Inflamm. 2008; 16 139-140

Google Scholar
24 Bhat P V, Jakobiec F A, Kurbanyan K et al. Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized clinical entity. Am J Ophthalmol. 2009; 148 779-789

Google Scholar
25 Jain V, Shome D, Natarajan S et al. Surgically induced necrotizing scleritis after pterygium surgery with conjunctival autograft. Cornea. 2008; 27 720-721

Google Scholar
26 Morley A MS, Pavesio C. Surgically induced necrotising scleritis following three-port pars plana vitrectomy without scleral buckling: a series of three cases. Eye. 2008; 22 162-164

Google Scholar
27 Nguyen D Q, Raman V S, Twomey J M et al. Keratectasia as a presentation of surgically induced necrotizing sclerokeratitis (SINS). Eye Contact Lens. 2007; 33 332-333

Google Scholar
28 Sainz de la Maza M, Foster C S. Necrotizing scleritis after ocular surgery. A clinicopathologic study. Ophthalmology. 1991; 98 1720-1726

Google Scholar
29 Salacz G. Postoperative necrotizing sclerokeratitis. Doc Ophthalmol. 1992; 80 167-170

Google Scholar
30 O’Donoghue E, Lightman S, Tuft S et al. Surgically induced necrotising sclerokeratitis (SINS) – precipitating factors and response to treatment. Br J Ophthalmol. 1992; 76 17-21

Google Scholar
31 McCluskey P J, Watson P G, Lightman S et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999; 106 2380-2386

Google Scholar
32 Sen H N, Sangave A, Hammel K et al. Infliximab for the treatment of active scleritis. Can J Ophthalmol. 2009; 44 e9-e12

Google Scholar
33 Doctor P, Sultan A, Syed S et al. Infliximab for the treatment of refractory scleritis. Br J Ophthalmol. 2010; 94 579-583

Google Scholar
34 Ahn S J, Oh J Y, Kim M K et al. Treating refractory scleritis with infliximab. Jpn J Ophthalmol. 2009; 53 286-287

Google Scholar
35 Kontkanen M, Paimela L, Kaarniranta K. Regression of necrotizing scleritis in Wegener’s granulomatosis after infliximab treatment. Acta Ophthalmol. 2010; 88 e96-e97

Google Scholar
36 Restrepo J P, Molina M P. Successful treatment of severe nodular scleritis with adalimumab. Clin Rheumatol. 2010; 29 559-561

Google Scholar
37 Kurz P A, Suhler E B, Choi D et al. Rituximab for treatment of ocular inflammatory disease: a series of four cases. Br J Ophthalmol. 2009; 93 546-548

Google Scholar
38 Chauhan S, Kamal A, Thompson R N et al. Rituximab for treatment of scleritis associated with rheumatoid arthritis. Br J Ophthalmol. 2009; 93 984-985

Google Scholar
39 Taylor S RJ, Salama A D, Joshi L et al. Rituximab is effective in the treatment of refractory ophthalmic Wegener’s granulomatosis. Arthritis Rheum. 2009; 60 1540-1547

Google Scholar
40 Benson W E. Posterior scleritis. Surv Ophthalmol. 1988; 32 297-316

Google Scholar
41 Sainz de la Maza M, Jabbur N S, Foster C S. An analysis of therapeutic decision for scleritis. Ophthalmology. 1993; 100 1372-1376

Google Scholar
42 Singh G, Guthoff R, Foster C S. Observations on long-term follow-up of posterior scleritis. Am J Ophthalmol. 1986; 101 570-575

Google Scholar
43 Calthorpe C M, Watson P G, McCartney A C. Posterior scleritis: a clinical and histological survey. Eye. 1988; 2 (Pt 3) 267-277

Google Scholar
44 Chaques V J, Lam S, Tessler H H et al. Computed tomography and magnetic resonance imaging in the diagnosis of posterior scleritis. Ann Ophthalmol. 1993; 25 89-94

Google Scholar
45 Watson P G. Anterior segment fluorescein angiography in the surgery of immunologically induced corneal and scleral destructive disorders. Ophthalmology. 1987; 94 1452-1464

Google Scholar
46 Watson P G. Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation. Trans Ophthalmol Soc U K. 1982; 102 (pt 2) 257-281

Google Scholar
47 Heiligenhaus A, Schilling M, Lung E et al. Ultrasound biomicroscopy in scleritis. Ophthalmology. 1998; 105 527-534

Google Scholar
48 Fong L P, Sainz de la Maza M, Rice B A et al. Immunopathology of scleritis. Ophthalmology. 1991; 98 472-479

Google Scholar
49 Kafkala C, Daoud Y J, Paredes I et al. Masquerade scleritis. Ocul Immunol Inflamm. 2005; 13 479-482

Google Scholar
50 Soukiasian S H, Foster C S, Niles J L et al. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener’s granulomatosis. Ophthalmology. 1992; 99 125-132

Google Scholar
51 Jabs D A, Mudun A, Dunn J P et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000; 130 469-476

Google Scholar
52 Gangaputra S, Newcomb C W, Liesegang T L et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009; 116 2188-2198

Google Scholar
53 Pasadhika S, Kempen J H, Newcomb C W et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009; 148 500-509

Google Scholar
54 Daniel E, Thorne J E, Newcomb C W et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010; 149 423-432

Google Scholar
55 Kaçmaz R O, Kempen J H, Newcomb C et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010; 117 576-584

Google Scholar
56 Iaccheri B, Androudi S, Bocci E B et al. Rituximab treatment for persistent scleritis associated with rheumatoid arthritis. Ocul Immunol Inflamm. 2010; 18 223-225

Google Scholar
57 Albini T A, Zamir E, Read R W et al. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis. Ophthalmology. 2005; 112 1814-1820

Google Scholar
58 Roufas A, Jalaludin B, Gaskin C et al. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis. Br J Ophthalmol. 2010; 94 743-747

Google Scholar
59 Sohn E H, Wang R, Read R. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for nonnecrotizing, noninfectious anterior scleritis. Ophthalmology. (in press)

Google Scholar
60 Zamir E, Read R W, Smith R E et al. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology. 2002; 109 798-805 ; discussion 805 – 797

Google Scholar
61 Jabs D A. Discussion. Ophthalmology. 2002; 109 806-807

Google Scholar
62 Fraunfelder F T, Watson P G. Evaluation of eyes enucleated for scleritis. Br J Ophthalmol. 1976; 60 227-230

Google Scholar
63 Cordero-Coma M, Franco-Benito M, García-Ruiz-de-Morales J M et al. Successful treatment of surgically induced necrotizing sclerokeratitis (SINS) with systemic immunosuppresive agents and amniotic membrane grafting. Arch Soc Esp Oftalmol. 2009; 84 577-580

Google Scholar
64 Sainz de la Maza M, Tauber J, Foster C S. Scleral grafting for necrotizing scleritis. Ophthalmology. 1989; 96 306-310

Google Scholar

Dr. Christoph Tappeiner

Universitätsklinik für Augenheilkunde, Inselspital

Freiburgstr. 10

3010 Bern

Schweiz

Phone: ++ 41/31/6 32 85 03

Fax: ++ 41/31/3 82 47 79

Email: christoph.tappeiner@insel.ch

>